The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

被引：0
|
作者：
Ahmed Yahia Elmowafy
Mohamed Hamed Abbas
Ahmed Abdelfattah Denewar
Mohamed Elsayed Mashaly
Gamal Shiha
Salwa Mahmoud El Wasif
Lionel Rostaing
Mohamed Adel Bakr
机构：
[1] Mansoura University,Urology and Nephrology Center
[2] Egyptian Liver Research Institute and Hospital,Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation Rénale
[3] Université Grenoble Alpes,undefined
[4] CHU Grenoble-Alpes,undefined
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; HCV infection; Sofosbuvir; Daclatasvir; Anemia; Kidney transplantation; Hemodialysis; DAA therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 761
页数：12
相关论文
共 50 条
  • [21] The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies
    Dabrowska, Maria
    Jaroszewicz, Jerzy
    Sitko, Marek
    Janocha-Litwin, Justyna
    Zarebska-Michaluk, Dorota
    Janczewska, Ewa
    Lorenc, Beata
    Tudrujek-Zdunek, Magdalena
    Parfieniuk-Kowerda, Anna
    Klapaczynski, Jakub
    Berak, Hanna
    Socha, Lukasz
    Dobracka, Beata
    Dybowska, Dorota
    Mazur, Wlodzimierz
    Wazny, Lukasz
    Flisiak, Robert
    CANCERS, 2024, 16 (17)
  • [22] Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
    Musa, Nevine Ibrahim
    Mohamed, Inas Elkhedr
    Abohalima, Ahmed Samir
    EGYPTIAN LIVER JOURNAL, 2020, 10 (01)
  • [23] Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
    Nevine Ibrahim Musa
    Inas Elkhedr Mohamed
    Ahmed Samir Abohalima
    Egyptian Liver Journal, 10 (1)
  • [24] Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection
    Piga, Antonio
    Rigano, Paolo
    Origa, Raffaella
    Cappellini, M. Domenica
    Pinto, Valeria
    Tartaglione, Immacolata
    Filosa, Aldo
    D'Ascola, Domenico
    Di Marco, Vito
    Forni, Gian Luca
    BLOOD, 2016, 128 (22)
  • [25] Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals
    Mendez-Sanchez, Nahum
    Coronel-Castillo, Carlos E.
    Ramirez-Mejia, Mariana Michelle
    PATHOGENS, 2024, 13 (04):
  • [26] Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease
    Villani, Rosanna
    Romano, Antonino Davide
    Sangineto, Moris
    Serviddio, Gaetano
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (05) : 1239 - 1245
  • [27] Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease
    Rosanna Villani
    Antonino Davide Romano
    Moris Sangineto
    Gaetano Serviddio
    Internal and Emergency Medicine, 2021, 16 : 1239 - 1245
  • [28] Efficacy of direct-acting antivirals on elimination of HCV and its effect on platelet in patients with chronic hepatitis C virus
    Salama, Basem M. M.
    Emola, Khaled
    Heiza, Mohamed
    MEDICAL SCIENCE, 2020, 24 (103) : 1600 - 1605
  • [29] New direct-acting antivirals for the treatment of chronic hepatitis C
    Jeong, Sook-Hyang
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2015, 58 (12): : 1154 - 1158
  • [30] Direct-acting antivirals for children and adolescents with chronic hepatitis C
    Indolfi, Giuseppe
    Serranti, Daniele
    Resti, Massimo
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (04): : 298 - 304
12345